Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Tocopherol-conjugated DNA/RNA heteroduplex oligonucleotides enhance brain and liver targeting

Nov. 5, 2015

TiGenix receives E.U. grant to support trial of Cx-611 in severe sepsis

Nov. 4, 2015

AM-Pharma discloses phosphatase-like proteins

Aug. 21, 2015

French investigators patent chimeric proteins for amyloidosis

May 20, 2015

Merck & Co. describes new Fc-containing polypeptides

May 6, 2015

Anti-inflammatory effects of amylin(28-33) described for the first time

April 30, 2015

BMS-938790, a PEG-adnectin targeting hIL-23, for treatment of inflammatory diseases

March 12, 2015

LG Life Sciences discloses necrosis and apoptosis inhibitors

March 12, 2015

Specific inhibition of NLRP3 shows potential for the treatment of inflammatory diseases

Feb. 20, 2015

Leading BioSciences cleared to begin phase II study of LB-1148 in septic shock

Feb. 5, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.